Entering a New Era in Sleep-Apnea Treatment
Obstructive sleep apnea is one of the most common respiratory disorders worldwide. Persons with obstructive sleep apnea can have loud snoring that is detrimental...
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
Excess adiposity is a reversible etiologic risk factor for obstructive sleep apnea. In this trial, tirzepatide reduced the apnea–hypopnea index of participants with obstructive...
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
Excess adiposity is a reversible etiologic risk factor for obstructive sleep apnea. In this trial, tirzepatide reduced the apnea–hypopnea index of participants with obstructive...
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
Brigatinib produced responses in 23% of all tumors in patients with NF2-related tumors (schwannomas, meningiomas, and ependymomas), with hearing improvement in approximately one third...
